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Background: The estimated HIV prevalence among pregnant women in Ethiopia is 1.2 percent and unfortunately
one of every 3 children born to these women gets infected with HIV. Elimination of these mother-to-child transmissions
(MTCT) of HIV is possible through HIV testing during pregnancy and taking antiretroviral medications. However, only 24
percent of the pregnant women living with HIV have yet received the medication needed to prevent the transmission
of HIV. Hence, there exists a concern that the rate of HIV infection among infants born to HIV positive mothers is
increasing. This study assessed the prevalence of HIV infection and associated factors among infants born to
women living with HIV, in South Gondar zone, Amhara region, Ethiopia.
Methods: Facility based document review was conducted upon 434 charts. The study participants were HIV
exposed infants enrolled from January to December 2012. The data were reviewed from all the 17 health facilities
which were providing PMTCT services in the zone. The study included 434 HIV exposed infants having an HIV
Deoxyribonucleic Acid (DNA) Polymerase Chain Reaction (PCR) test result. The data were collected using
structured data extraction tool. Binary logistic regression analysis was employed to assess the putative association
of independent variables with the outcome variable. Significance was taken at a P value <0.05 and 95%
confidence level.
Result: The prevalence of HIV among HIV exposed infants was 10.1% (95% CI = 7.3 - 13%). Delayed diagnosis
(AOR = 2.7, 95% CI = 1.3, 29.4), mixed infant feeding (AOR = 8.8, 95% CI = 4.5, 22.8), failure to receive either
antiretroviral therapy or prophylaxis during pregnancy or breast feeding (AOR = 21.6, 95% CI = 14.5, 39.8) and
shorter duration of HIV treatment (AOR = 12, 95% CI = (4.2, 45.0) were the factors that increase the risk of
mother- to- child transmission of HIV.
Conclusion: The prevalence of HIV infection among HIV exposed infants is strikingly high. Inadequate use
of antiretroviral therapy and skilled delivery care were the factors that enhance mother-to-child transmission
of HIV.
Integrated and audience specific education and promotion for seeking obstetric care and HIV services is instrumental
to curb the devastating consequences of HIV on pregnant women and their newborns
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Globally, about 330,000 children were infected with HIV
in 2011, with over 90% of these infections occurring in
sub-Sahara Africa, and mainly through mother-to-child
transmission [1]. Twenty two countries account for
more than 90% of the global burden. Ethiopia is one of
these priority countries where one in every 3 children
born to a woman living with HIV gets infected with
HIV [1-3].
Disease progression is aggressive if infants acquire the
infection before or during the time of delivery [4]. If left
untreated, almost half of these children will die before
turning to second year, and 75% of them die by the age
of five years. Most of these deaths in children with HIV
could have been avoided through early infant diagnosis
(EID) and provision of effective care and treatment. In-
terventions like the use of Antiretroviral (ART) drugs by
infected pregnant women, safe delivery practices and
safe infant feeding have helped reduce the risk of trans-
mission to infants (from 40%to 5%) [1,5].
In Ethiopia an estimated 1.2 percent of pregnant
women are living with HIV. Consequently, one of every
3 children born to these women is being infected with
HIV [1,2]. Elimination of these mother-to-child trans-
missions (MTCT) of HIV would be possible through
HIV testing during pregnancy and taking antiretroviral
medications. Hence, the government of Ethiopia has
been expanding various preventive measures and services
against this Mother-To-Child Transmission (PMTCT). To
combat infections among infants and keep mothers alive,
a comprehensive package of interventions, including
provision of appropriate HIV treatment, and care and sup-
port services have been scaled up across the regions in
Ethiopia [6].
Moreover, since March 2013 all HIV positive pregnant
women in Ethiopia, perhaps in the region, have been eli-
gible to start long term antiretroviral therapy (ART)
through a transition to a new treatment package known
as option B+. Implementing this package is a critical
step towards eliminating at least 98% of these mother-
to-child transmissions of HIV [5,6].
Despite the availability and scale up of these life-saving
interventions, only 24% of pregnant women living with
HIV in the region have been receiving the medication to
prevent mother-to-child transmission of HIV [1,3].
Moreover, among women who utilize skilled delivery
services (12%) [2], most often go untested for HIV, with
devastating consequences for themselves and their new-
borns. As a result of this trend, there is a growing con-
cern that the risk of mother-to-child transmission of
HIV in the region, perhaps in the south Gondar zone,
Amhara may be increasing [1,3].
Early diagnosis of infections among infants with HIV
followed by prompt ART treatment can help reducemorbidity and mortality among them. Failing to do this
will usually lead to rapid disease progression and death.
Almost 50% of the infants infected during pregnancy or
delivery died within their one year age, while about 50%
of the children infected during breastfeeding died within
nine years of the infection [6,7].
In infants, antibody testing to diagnose HIV infection
is inadequate, as the passively acquired maternal anti-
bodies in the infant may yield false-positive results for
up to 18 months or longer. It is, therefore, important to
provide accurate diagnostic services for identifying of in-
fants infected with HIV. Because of its high sensitivity
and specificity, DNA polymerase chain reaction (PCR)
has been widely used for diagnosis of HIV amongst ex-
posed infants. This technology involves the use of a
small spot taken as a Dried Blood Spot (DBS) sample,
and can also be employed for identification of infection
at birth [7]. This is a molecular test service, which has
been successfully implemented in major regions in
Ethiopia. We only enrolled those HIV exposed and DBS
tested infants in the zone.
In Ethiopia, few studies [7,8] tried to demonstrate the
risk of mother-to-child transmission of HIV. However,
they were either confined to a single facility or assessed
the risk among urban dwellers only or used relatively re-
mote data. Consequently, assessing the risk and deter-
minant factors in the entire zonal administration that
involve both urban and rural families through enrolling
all health facilities that provide PMTCT service and
using relatively latest data available would, however, jus-
tify the importance of this research. In this study, we
aimed to determine the prevalence and associated fac-
tors of HIV infection among HIV exposed infants in
South Gondar zone, Amhara region, Ethiopia.Methods
A facility based cross-sectional study design was employed
from January to June 2013 to collect the data from the
registration and follow up log books in the PMTCT and
HIV exposed infants’ (HEI) follow-up units.
This study was conducted in South Gondar zone,
which is one of the 11 administrative zones in Amhara
National Regional State, Northwest Ethiopia. Amhara re-
gion is the second largest and most populous regional
state in Ethiopia. It has a total of 19.2 million people. It
is one of the hardest HIV/AIDS-hit regions in the coun-
try. The prevalence of HIV among adults and pregnant
women in the region is 1.5% and 0.8% respectively [2].
The south Gondar administrative zone is inhabited by
about 2.4 million people, and is administratively divided
into 12 districts and 5 town administrations [9]. The
burden of HIV in the zone, if not worst, may not be dif-
ferent from the regional estimate.
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ters, all of which are providing PMTCT services. The
study was conducted in all of these facilities. The data
collection was conducted from January to June 2013.
The study population involved HIV-exposed infants
enrolled in all health facilities providing PMTCT services.
The data were extracted from all registered HIV exposed
and DNA/ PCR tested infant charts documented from
January 1st to 31st December 2012.
Records were considered eligible for inclusion if an in-
fant’s age at diagnosis was recorded. They were also con-
sidered eligible for inclusion if both infant and maternal
HIV treatment and prophylaxis data are available, and if
information is available on infant feeding practice, place
of delivery and DNA/PCR test result. Based on this
notion, 434 charts were identified and enrolled in the
study.
DNA/PCR test result was the dependent variable,
while characteristics that might determine the risk of
HIV infection such as time of HIV testing, intake of
prophylaxis by infants, maternal ART or ARV prophy-
laxis intake, place of delivery, infant feeding practice,
maternal education, monthly income and duration of
treatment were the independent variables.
A structured data extraction tool was developed, pre-
tested and used to collect the information from the
charts. The tool was adapted from the national standard
HIV exposed infant follow up formats and PMTCT
registration log book, which comprises, socio-demographic
characteristics, information on ARV prophylaxis for the
mother and infant, place of delivery and infant feeding
practice and some other important variables. One ART
trained nurse and one ART trained health officer or mid-
wife in each health facility were recruited to collect the
data.
Training was given for data collectors and supervisors
one day. The collected data were reviewed daily for
completeness, accuracy, clarity, and consistency by the
supervisors and the principal investigators. Then codes
were given to the completed questionnaires. The data
were cleaned and edited before being entered into EPI-
info version 3.5.2. After the data were checked for cor-
rect entry into EPI-info, they were exported into SPSS
version 16 software for analysis. Further data cleaning
and frequency run was made to check for accuracy, out-
liers, consistencies and missed values and variables. Any
error identified was corrected.
Frequency run, cross tabulations and summary statis-
tics were used to describe the study population in rela-
tion to relevant variables. Crude and adjusted odds
ratios were computed to assess presence of association
and the magnitude of statistical significance. A P-value
of less than 0.05 at 95% CI data was considered statisti-
cally significant. Binary logistic regression analysis wasemployed to determine the effect of each independent
variable on the outcome variable and to control for the
effect of confounding.
Ethical clearance was obtained from Debre Markos
University ethical clearance committee. Official letter
was also sought from Amhara Regional State Health
Bureau and South Gondar zonal Health department.
The zonal health department and each district health
office offered letters to inform individuals in charge of
all eligible health facilities. The data retrieved from
each health center’s HIV exposed infant records and
PMTCT registration log books were entirely used an-
onymously and the files used did not bear any name or
identification number. The collected data were kept
strictly confidential.
Result
Among the total 455 reviewed HIV exposed infants’
(HEI) and HIV positive pregnant women's records, 434
charts were found to have complete information and
then enrolled for the study.
Socio-demographic characteristics of the study
participants
Female HEI infants constitute 51.6%, whereas the
remaining 48.4% were males. Age at the time of diag-
nosis for the majority (58.8%) of infants was between
6 weeks and 6 months of age.
Majority (85.9%) of the women were married at the
time of enrollment in HIV care and support service.
More than half (66.8%) of the enrolled HIV positive preg-
nant women were unable to read and write. In addition,
majority (57.8%) of the mothers were housewives in
occupation.
Findings on HIV care and support
Nearly 93% of HIV positive women were enrolled in
HIV care and support service during the last pregnancy
period. Among these enrolled 402 HIV positive pregnant
women, 63.4% were taking highly active ART and 30.3%
were put on ARV prophylaxis. Three hundred twenty
eight (75.6%) infants were born in health facilities where
skilled delivery care was available. Moreover, 351 (81%)
of these newborns were given ARV prophylaxis right
after birth. Pertaining to the duration of ART treatment
a pregnant woman received, 338 (89.7%) mothers had
received the treatment for longer than four weeks
(Table 1).
The majority (351 or 80.9%) of the newborns born to
HIV positive women were given ARV prophylaxis ac-
cordingly, however, 83 (19.1%) did not receive any
prophylaxis at all. Among infants who received ARV
prophylaxis, the majority (141 or 40.2%) had taken single
dose Nevirapin plus AZT for seven days. The remaining
Table 1 Socio-demographic characteristics of HIV
exposed infants and their mothers, South Gondar,
Amhara, Ethiopia (n = 434), July 2013
Variables Number Percentage
Sex of the Infant
Male 210 48.4
Female 224 51.6
Age of the mother
15-24 95 21.9
25-34 260 59.9
> = 35 79 18.4
Marital status of the mother
Currently married 373 85.9
Currently not married 61 14.1
Educational status of the mother
Unable to read and write 251 57.8
Able to read and write 183 42.2
Occupational status of mother
House wife 290 66.8
Governmental employed 22 5.1
Unemployed 122 28.1
Number of children a mother has
1-3 369 85
4 and above 65 15
Table 2 Findings on HIV care and support of HIV exposed
infants and their mothers, South Gondar, Amhara,
Ethiopia (n = 434), July 2013
Variables Number Percentage
Infant’s age at DBS testing
At 6 weeks 110 25.3
6 weeks to 6 months 255 58.8
After 6 months 69 15.9
Infants Received CPT at 6 weeks of birth
Yes 377 86.9
No 57 13.1




Exclusive Breast feeding 402 92.6
Replacement feeding 0 0
Mixed feeding 32 7.4
Mothers enrolled in HIV/ART care
Yes 402 92.6
No 32 7.4
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ceived daily Nevirapin for 45 days, single dose Nevirapin,
daily Nevirapin until cessation of breastfeeding and sin-
gle dose Nevirapin plus AZT for 28 days, respectively.
Pertaining to breast feeding, 402 (92.6%) infants were
given exclusive breastfeeding, and the remaining 32 (7.4%)
was put on mixed feeding. At the time of the study, 390
(89.9%) infants were on active follow up, whereas 32
(7.4%) children were lost to follow up services and 12
(2.8%) children reportedly died.
With regard to the time of diagnosis of infants born to
HIV positive mothers, the majority (255 or 58.8%) had
their DBS tested between 6 weeks and 6 months. While
only 110 (25.3%) infants were tested at the right time,
which was at 6 weeks and the remaining 69 (15.9%) had
their DBS test after 6 months (Table 2). The mean age at
which DBS test done was 17 weeks.Result of HIV testing among HEIs
The prevalence of HIV infection among the infants born
to HIV positive mothers was 10.1% (44 out of 434 infants)
(Figure 1), with a 95% confidence interval between 7.3%
and 13%.Bivariate analysis of factors associated with DNA/PCR
result
Infants who got DBS tests after 6 months of their age
were more likely to have positive test results than their
counterparts (COR = 9.24, 95% CI = (3.5, 24.2)). Infants
born to mothers in the age range between 25–34 years
were more likely to have positive DNA/PCR test results;
however, it has no statistically significant association
(COR = 1. 4, 95% CI = 0. 6, 4.9).
Infants their DBS tested after 6 months were more
likely to have positive HIV results than their counter-
parts (COR = 9.24, 95% CI = (3.5, 24.2)). Infants born to
mothers in the age range between 25–34 years were
more likely to have higher odds of positive DNA/PCR
positivity than other age categories; however, it has
no statistically significant association (COR = 1. 4, 95%
CI = 0. 6, 4.9) with the outcome variable.
On the other hand, infants born to mothers with no
education were also more likely to be DNA/PCR positive
than infants born from educated mothers (COR = 8.4,
95% CI = 2.9, 14.8). Also, all DNA/PCR positive infants
were born to mothers having few (1–3) numbers of chil-
dren. Besides, infants who did not receive ARV prophy-























Figure 1 DNA/ PCR Test results of HEI, South Gondar Zone, Amhara, 2013.
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observed between taking either ARV or ART and HIV test
result.
Those infants who received mixed feeding in the first
six months of their life time were more likely to be
DNA/PCR positive than those children who only received
exclusive breastfeeding (COR = 12. 4, 95% CI = 6.0, 18.1).
Meanwhile, mothers who were not enrolled in HIV care
and support service had relatively higher risks of giving
birth to HIV HIV positive infants than their counterparts
(COR = 6. 9, 95% CI = (3.1, 15.4).
Infants born to mothers who received neither ART nor
ARV prophylaxis were more likely than their counterparts
to have positive result (COR = 16.0, 95% CI = (6.8, 24.9).
Moreover, those infants whose mothers had taken ART or
ARV prophylaxis for a duration of less than 4 weeks were
more likely to be DNA/PCR positive (COR = 23.8, 95%
CI = 8.8, 39.0). Lastly, infants born at home were more
likely to be DNA/PCR positive than those born at health
facilities (COR = 8.8, 95% CI = (4.4, 17.5) (Table 3).
Results of multivariate analysis
We entered the variables that had a P value < 0.2 in the
bivariate analysis (crude) to the final multivariate (adjusted)
analysis model.
To begin with, those infants who took DBS tests after
6 months of their age were more likely to have positive
DNA/PCR results (AOR = 1. 3,95% CI = 1.1, 10.1) than
those tested in the earlier ages. On the other hand,infants who did not receive any prophylaxis were 6.7
times higher to become HIV positive than protected
children (AOR = 6.7, 95% CI = 2.9, 23.1). Mixed feeding
was also significantly associated with HIV positive test
results (AOR = 8.8, 95% CI = 4.5, 22.8). Moreover, infants
born to women who did not receive either ART or ARV
prophylaxis during pregnancy or breastfeeding were
found to have a higher likelihood of contracting HIV
from their mothers. Similarly, infants born to mothers
who did not receive ART or ARV prophylaxis at all or
who received it for less than 4 weeks, were found to be
with increased likelihood (21.6% and 12%, respectively )
of being HIV positive (AOR = 21.6,95% CI = 14.5, 39.8)
(AOR = 12, 95% CI = (4.2, 45) (Table 4).
However, maternal education and history of enroll-
ment that had significant association in the bivariate
analysis were not found to have significant association
when adjusted for confounding factors in the final multi-
variate logistic regression model.
Discussion
Infants who get infected during pregnancy or while
breastfeeding require early HIV diagnosis and timely
treatment. As a standard testing mechanism to diagnose
HIV infection, DNA/PCR testing services have been ex-
panded in Ethiopia, including Amhara region. Following
the expansion of HIV DNA/PCR testing facilities in the
region, DBS samples have been collected and tested
from all infants born to HIV positive pregnant women.
Table 3 Bivariate Analysis of factors associated with HIV positivity, South Gondar, Amhara, Ethiopia July 2013
DBS Result COR (95% CI) P value
Negative Positive
Age at DBS tested
At 6 week 104 6 1 0.002
6th week to 6 months 241 14 1.00 (0.37, 2.69)
After 6 months 45 24 9.24 (3.5,24.2)*
Mothers’ Age
15-24 83 12 1 0.761
25-34 234 26 1.7 (0.6, 4.6)
35+ 73 6 1.3 (0.5, 3.4)
Maternal Education
Unable read & write 211 40 8.4 (2.9, 14.8)* 0.013
Able to read & write 179 4 1
Infant ARV prophylaxis
Yes 337 14 1 0.0001
No 53 30 10.6 (3.5, 13.8)*
Place of delivery
Health facility 314 14 1 0.0001
Home 76 30 8.8 (4.4, 17.5)*
Feeding practice
EBF 374 28 1 0.0001
MF 16 16 12.4 (6.0, 18.1)*
Infants enrolled for HIV care & support
Yes 370 32 1 0.004
No 20 12 6.7 (3.1, 15.4)*
Mothers’ treatment
ART 245 10 1 0.0001
ARV prophylaxis 110 12 2.6 (1.1, 6.3)*
None 15 10 16.0 (6.8, 24.9)*
Duration of treatment
>4 weeks 330 8 1 0.0001
<=4 weeks 25 14 23 (8.8, 39)*
*Statistically significant at P value less than 0.05 and 95% CI.
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tion rate with a single test, only the results of PCR for
HIV DNA antigen in DBS samples of HEIs were used.
In this study, the prevalence of HIV infection among
HIV exposed infants was 10.1%, which was incompar-
able to the national estimate of 10.9% [3]. This slight dif-
ference may be due to the enrollment of a relatively
smaller number of samples in our study. Given a num-
ber of interventions have been implemented to curb the
prevalence of mother to child transmission of HIV, the
result in this study could still be considered alarming.
Having such a burden during the era of UN’s pledge to
eliminate MTCT of HIV by December 31st, 2015 [5], isreally a challenge to be on the track and avoid needless
deaths of these precious natives of tomorrow. This find-
ing clearly indicated that the progress that has been
made to produce an HIV free generation is very slow.
This study demonstrated that a number of factors are
related to MTCT of HIV. It is consistent with other
studies which revealed that infants having their DBS test
done after 6 months of their age were more likely to be
HIV positive than infants tested at the age of 6 weeks or
between 6 weeks and 6 months [10-13]. This observa-
tion may be due to the fact that the older the infants
were when they got into health facilities for diagnosis,
the more they were likely to be exposed to HIV infection
Table 4 Multivariate Analysis of factors associated with HIV positivity, South Gondar Amhara, Ethiopia July 2013
Variables DBS Result COR (95% CI) AOR (95% CI)
Negative Positive
Age at DBS tested
At 6 week 104 6 1 1
6th week to 6 months 241 14 1.00 (0.4, 2.7) 0.56 (0.17, 1.81)
After 6 months 45 24 9.2 (3.5,24.2)* 2.7 (1.3, 29.4)*
Maternal Age
15-24 83 12 1 1
25-34 234 26 1.7 (0.6, 4.6) 1.3 (0.2, 6.7)
35+ 73 6 1.3 (0.5, 3.4) 0.5 (0.1, 3.0)
Maternal Education
Unable to read & write 211 40 8.4 (2.9, 14.8)* 4.2 (0.8,21.4)
Able to read & write 179 4 1 1
Place of delivery
Health facility 337 14 1 1
Home 53 30 10.6 (3.5,13.8)* 6.1 (2.1, 18.6)*
Infant ARV prophylaxis
Yes 314 14 1 1
No 76 30 8.8 (4.4, 17.5)* 6.7 (2.9, 23.1)*
Feeding practice
EBF 374 28 1 1
MF 16 16 12.4 (6.0,18.1)* 8.8 (4.5, 22.8)*
Infants enrolled for HIV care & support
Yes 370 32 1 1
No 20 12 6.9 (3.1, 15.4)* 2.5 (0.6, 10.1)
Mothers’ treatment
ART 245 10 1 1
ARV prophylaxis 110 12 2.6 (1.1, 6.3)* 3.1 (0.7,12.8)
None 15 10 16.0 (6.8,24.9)* 21.6 (14.5, 39.8)*
Duration of treatment
>4 weeks 330 8 1 1
<=4 weeks 25 14 23 (8.8, 39)* 12 (4.2, 45)*
Adjusted for age at DBS tested, maternal age, maternal education, feeding practice, place of delivery and prophylaxis.
*Statistically significant at P value less than 0.05 and 95% CI.
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have doubled if weaning was not correctly practiced and
if a mother is not enrolled in HIV care and support dur-
ing pregnancy, labor and post-partum period. Maternal
ART and infants’ARV prophylaxis are effective interven-
tions to curb MTCT of HIV during this time [3-5].In
addition, early infant diagnosis and enrollment in HIV
care and support services would have reduced the chance
of mother-to-child-transmission of HIV among HEIs, pro-
vided that weaning was correctly practiced.
Infants born at home were 6.7 times more likely to be
HIV positive than those born at health facilities. This isdue to the fact that HIV positive women attending skilled
delivery service would be given antiretroviral treatment
or antiretroviral prophylaxis to prevent mother to child
transmission of HIV during labor and delivery. More-
over, HIV exposed newborns may have the opportunity
to receive ARV prophylaxis immediately, thereby min-
imizing the risk of acquiring HIV infection during labor
and delivery as the highest proportion of newborns are
infected during this time. This finding is consistent with
studies done in Ethiopia and Tanzania [13-15]. However,
in this study a considerable number of pregnant women
did not attend skilled delivery care, leaving the devastating
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efforts are needed to ensure that all pregnant women are
receiving skilled delivery services.
Those infants born to mothers who did not receive ei-
ther ART or ARV prophylaxis were 21.6 times more likely
to have a risk of acquiring HIV infection than their coun-
terparts. Taking ART could reduce maternal viral load and
subsequent transmission of the virus to the fetuses or
newborns. Those mothers who did not have a history of
treatment were more likely to get their babies infected
than their counterparts. This finding is consistent with
studies done elsewhere [13,15,16]. Without treatment, up
to 40% of babies born to HIV positive mothers will start
life being infected, and almost half of these will die before
they are two years old [4,5]. Therefore, there should not
be any reluctance or missed opportunity to enroll all HIV
positive pregnant women for available HIV care and sup-
port services.
Another predictor of mother- to- child transmission of
HIV concerned in this study was the use of infanthood
ARV prophylaxis. Hence, those infants who did not re-
ceive ARV prophylaxis right after birth were at risk of
acquiring HIV infection. This might be due to the effect
of these drugs to reduce the virus concentration in the
newborn’s blood. In fact this was in harmony with results
of studies done in Ethiopia and Zambia [6,8,10,13,14] but
not with others [15-17].
Being consistent with studies done in Ethiopia [13]
and Kenya [17], infants who received mixed feeding
were 9 times more likely to acquire HIV infection than
their counterparts. This could be due to contamination
of the food during preparation or feeding that might
have involved in gastrointestinal infection and laceration
which may have led to mucosal barrier breakage and
subsequent viral entry to the blood stream and progres-
sion of HIV infection [11,18]. Mothers’ lack of knowledge
on the adequacy of breastfeeding to satisfy nutritional de-
mands of their (<6 months) infants might contribute to
the observed mixed feeding practice in the region.
There might be missed opportunities such as not giv-
ing advice for mothers’ of HEIs on infant feeding option
during antenatal follow up visits, delivery or postpartum
period. As breast feeding is the most preferred nutri-
tional option for HEIs younger than 6 months [6], we
have to make sure that every mother has the right infor-
mation and means to make appropriate decisions.
Moreover, duration of ART treatment also determines
the probability of MTCT of HIV. If pregnant women are
on ART treatment for longer than 4 weeks, they would
be less likely to transmit HIV to their babies. This obser-
vation might be attributed to the effect of the treatment
on the viral load and subsequent transmission. This
finding is in consistence with other studies [15,16,18,19].
This finding underscores the critical need of earlierdiagnosis and timely treatment of HIV among pregnant
women.
However, most pregnant women were not coming for
ANC at all or were very late, although access to the
ANC service was fairly available in the region. The re-
gional health bureau, zonal health departments and dis-
trict health offices should collaborate and strive to
ensure that integrated and continuing education and
promotion is given to all pregnant women regarding the
need for ANC follow up and use of skilled delivery ser-
vice including utilization of HIV care and support ser-
vices. This strategy would eventually ensure elimination
of MTCT of HIV in the region.
Unlike other previous studies [8,13], maternal education
and history of enrollment of children for HIV care and
support did not show a statistically significant relationship
with the outcome variable in the final model. This vari-
ation may be due to the difference in sample size, study
area, study design, method of analysis or could be also at-
tributed to the quality of data captured.
Limitation of the study
As this research was conducted using secondary data re-
corded on paper-based system only, it was impossible to
obtain some essential information in the charts, such as
partner HIV status, household monthly income, mater-
nal viral load during pregnancy and whether she was in-
fected before or during the last pregnancy.
Some variation in recording of client information among
facilities might also have introduced reporting bias. The
relatively small sample size might also affect the power of
the test. Therefore, generalization of the findings of this
study may not be possible. Although this study might suf-
fer from its lower precision, its results would be valuable
evidences to evaluate program effectiveness and provide a
foundation for future intervention.
Conclusion
Depending on all the findings deliberated so far, therefore,
it is possible to conclude that the prevalence of HIV in-
fection among HEI is strikingly high. Delay in seeking
HIV testing services, failure to seek skilled delivery ser-
vice, mixed infant feeding practice and failure to provide
or shorter duration of HIV treatment were the factors
that increased the risk of mother- to- child transmission
of HIV. Consequently, there is a lot to be done by all
the various stakeholders. Health authorities at all levels
of the region should work together to ensure that all
pregnant women are using ANC and skilled delivery
services.
Integrated and audience specific education and promo-
tion on using comprehensive HIV care and support ser-
vices which include timely HIV testing of HIV exposed
infants should be strengthened. Research is needed to
Berhan et al. BMC Research Notes 2014, 7:876 Page 9 of 9
http://www.biomedcentral.com/1756-0500/7/876explore reasons related to infant mortalities or failures
in follow-up of HIV care services in the region. Assessing
the risk among clients visiting private providers may also
reveal valuable information. Future researchers should
consider the use of larger sample size and also the possi-
bility of assessing the factors turned out to be insignificant
in this study.
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